IL1B and neoplasm: We also monitored the body weight of tumor-bearing mice during the treatment course and found that IL-1β only caused a transient weight loss regardless of the infusion of Pmel-1 cells (Fig. 1 G), and no mortality unrelated to tumor burden was observed.